Grifols (GRFS) Beginning Cash Balance (2011 - 2020)
Grifols' (GRFS) quarterly Beginning Cash Balance came in at $819.1 million in Q1 2020, down 30.29% YoY from $1.2 billion in Q2 2019, and down 28.42% on a QoQ basis from $1.1 billion in Q4 2019.
Grifols (GRFS) Beginning Cash Balance (2011 - 2020) Analysis & Trends
Grifols (GRFS) has 9 years of Beginning Cash Balance data on file, last reported at $819.1 million in Q1 2020.
- Quarterly Beginning Cash Balance fell 30.29% year-over-year to $819.1 million in Q1 2020, while the trailing twelve-month figure through Mar 2020 was $4.2 billion (up 26.69% YoY) and the FY2019 annual result came in at $1.1 billion, up 13.09% from the prior year.
- Beginning Cash Balance eased to $819.1 million in Q1 2020, from $1.1 billion in the prior quarter.
- In the past five years, Beginning Cash Balance ranged from a high of $1.2 billion in Q1 2019 to a low of $819.1 million in Q1 2020.
- A 4-year average of $1.0 billion and a median of $1.1 billion in 2017 frame the typical range for Beginning Cash Balance.
- Annual changes were most pronounced in 2018 — Beginning Cash Balance climbed 14.22% — and 2020, when it tumbled 30.29%.
- Tracing GRFS's Beginning Cash Balance over 4 years: stood at $1.1 billion in 2017, then declined by 3.98% to $1.0 billion in 2018, then advanced by 13.09% to $1.1 billion in 2019, then retreated by 28.42% to $819.1 million in 2020.
- The last three Beginning Cash Balance figures came in at $819.1 million (Q1 2020), $1.1 billion (Q4 2019), and $1.2 billion (Q1 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Grifols | 5.45 Bn | 4.45 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 819.10 Mn |
| Mar 31, 2020 | 819.10 Mn |
| Dec 31, 2019 | 1.14 Bn |
| Dec 31, 2019 | 1.14 Bn |
| Mar 31, 2019 | 1.18 Bn |
| Mar 31, 2019 | 1.18 Bn |
| Dec 31, 2018 | 1.01 Bn |
| Dec 31, 2018 | 1.01 Bn |
| Mar 31, 2018 | 1.09 Bn |
| Mar 31, 2018 | 1.09 Bn |
| Dec 31, 2017 | 1.05 Bn |
| Dec 31, 2017 | 1.05 Bn |
| Mar 31, 2017 | 953.55 Mn |
| Mar 31, 2017 | 953.55 Mn |
| Mar 31, 2015 | 1.22 Bn |
| Mar 31, 2015 | 1.22 Bn |
| Sep 30, 2014 | 939.81 Mn |
| Sep 30, 2014 | 939.81 Mn |
| Jun 30, 2014 | -971.38 Mn |
| Jun 30, 2014 | -971.38 Mn |